Insiders who reported open-market trades in the last 12 months at the companies Christopher A. Kroeger files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Catalyst4, Inc. - $191.21M in MPLT purchases and sales in the last 12 months
Novo Holdings A/S - $16.20M in MPLT purchases and sales in the last 12 months
Jonathan Gillis - $3.56M in MPLT purchases and sales in the last 12 months
Erin Pennock Foff - $3.38M in MPLT purchases and sales in the last 12 months
Anatol Kreitzer - $2.78M in MPLT purchases and sales in the last 12 months
Christopher A. Kroeger is a corporate insider, tracked as Chief Executive Officer, Director of MapLight Therapeutics, Inc. (MPLT). InsiderAlpha holds 9 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Christopher A. Kroeger submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Christopher A. Kroeger been buying or selling stock?
Recorded transactions: 0 open-market purchases and 29 open-market sales ($12.54M) across all tracked filings.
Christopher A. Kroeger is Chief Executive Officer, Director of MapLight Therapeutics, Inc. (MPLT). 9 SEC Form 4 filings on record going back to 2025, most recently on 19 August 2026. Most recent open-market trade: sold $636K of MPLT on 18 July 2026. Lifetime open-market sales: $12.54M.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by Christopher A. Kroeger.
InsiderAlpha's records for Christopher A. Kroeger go back to 2025: 9 primary Form 4 filings, an average of 4.5 per year. 19 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
